Trillium Therapeutics Inc.
BioTech/Drugs - Mississauga, ON, CA
Trillium Therapeutics Inc. Employees
Trillium Therapeutics Inc. Senior Management
Trillium Therapeutics Inc. Details
Trillium Therapeutics Inc. (NASDAQ/TSX:TRIL) is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. We have a strong focus on CD47, a molecule that tumors frequently use to evade the immune system. CD47 is a protective "do not eat" signal that blocks the ability of certain immune cells to destroy the tumor. By blocking this "do not eat" signal with decoy receptors, we aim to unmask tumor cells and make them visible to, and eradicated by, the immune system.
Website:
trilliumtherapeutics.com
Employees:
50 - 99
HQ:
857-412-7029
Location:
Mississauga, ON, CA
Revenue:
5 - 10 Million
Trillium Therapeutics Inc. Technologies
Domain Name Services
Dyn Managed DNS
Web Performance Monitoring
New Relic
Hosting
DigitalOcean
Other
Google Maps
Analytics and Tracking
Google Analytics